about
Assessment of anthelmintic efficacy of mebendazole in school children in six countries where soil-transmitted helminths are endemicAssessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemicA comparison of the sensitivity and fecal egg counts of the McMaster egg counting and Kato-Katz thick smear methods for soil-transmitted helminthsAn immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areasThe Right Tool for the Job: Detection of Soil-Transmitted Helminths in Areas Co-endemic for Other HelminthsElevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini.Microproteinuria during Opisthorchis viverrini infection: a biomarker for advanced renal and hepatobiliary pathologies from chronic opisthorchiasis.Elevated serum levels of interleukin-6 in endemic Burkitt lymphoma in Ghana.The metastasis-associated protein-1 gene encodes a host permissive factor for schistosomiasis, a leading global cause of inflammation and cancerInflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humansA history of hookworm vaccine development.Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine.Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response.Potency testing for the experimental Na-GST-1 hookworm vaccine.Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines.Immunology of experimental and natural human hookworm infection.Identification of genotypes of Giardia intestinalis of human isolates in Egypt.Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica.Phenotypic analysis of adults of Fasciola hepatica, Fasciola gigantica and intermediate forms from the endemic region of Gilan, Iran.Phenotypic comparison of allopatric populations of Fasciola hepatica and Fasciola gigantica from European and African bovines using a computer image analysis system (CIAS).Correction: Microproteinuria during Opisthorchis viverrini Infection: A Biomarker for Advanced Renal and Hepatobiliary Pathologies from Chronic Opisthorchiasis.Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.Anaemia in advanced chronic fasciolosis.Human and animal fascioliasis in Mazandaran province, northern Iran.MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. giganticaMM3-ELISA detection of Fasciola hepatica coproantigens in preserved human stool samplesCrowding effect on adult growth, pre-patent period and egg shedding of Fasciola hepaticaOperational satellite-based temporal modelling of Aedes population in ArgentinaPrevalence of intestinal parasites and the absence of soil-transmitted helminths in Añatuya, Santiago del Estero, ArgentinaRisk map development for soil-transmitted helminth infections in ArgentinaHow to implement the framework for the elimination of mother-to-child transmission of HIV, syphilis, hepatitis B and Chagas (EMTCT Plus) in a disperse rural population from the Gran Chaco region: A tailor-made program focused on pregnant women
P50
Q21092267-BF8A590A-A975-4A38-AFC2-AD5D56823F33Q28477545-43F79DC8-CBDB-4CA1-BF9F-E26C1F1452B9Q28478558-1225F3AE-4E82-4BE1-B9AB-3722415E5831Q28541675-182ACB4C-75EA-4CEF-B3AD-0B41B240C8B4Q28546989-603BA540-55B7-4B6B-9855-F258FB01D4A4Q34282235-365F051F-F575-47E2-BF94-2C0BAB07AA66Q34746708-AB263575-C8D2-4B72-B90B-1D8430041D1BQ34942431-F59A1563-7796-4522-A8FF-CC80F918B6D2Q35074527-C43CF0B0-58F4-4FBE-B54F-8B8FA028DE6CQ35249205-B0FE00A3-4975-491E-B05E-D0C534FA2EC6Q35881296-3DCD3958-E085-4DA5-B848-A8F726AA011AQ36278451-8F2E43F1-AA36-446E-A351-AD236E2243E9Q37065688-0C51550F-91AE-479C-AAA0-8D206DCC0B81Q37798012-ACBF2620-F50A-432B-9C2F-6F01DD1131D0Q38022339-245ECAF2-A387-4FCE-96DD-2B174D320CCEQ38261957-C8EC05DC-850C-479E-9D3E-67494619281EQ39008514-437C6478-4A6C-44F8-9AEC-711BC40234C6Q39546300-D7508049-9BB2-41C4-818D-0238A601C1FBQ43933110-3E3F2F88-7103-4B89-8A9F-7AA953CB19A6Q43933254-B4CDBBD6-713B-4477-AFC8-269C48DB36D8Q45767223-3ABE5C3F-9446-4254-B7BF-957B4CF533A5Q47709317-2D87C7F0-E90C-41E4-ABFC-FDA6D7E407C5Q50634400-1586339D-E253-43C9-BC0D-9495E9E7216EQ50748310-3096FA0D-107E-4403-8E35-93386FFBF80BQ57609852-F172A926-8713-4F93-933F-83F16965F175Q58959520-8438B0BC-508D-4E7E-BA26-A7476069DD1EQ58959602-F2DFBD9B-C50E-4676-9A1C-54A719E06D56Q59245642-7DB582DE-D9D7-4D18-923F-F2211508C43FQ60044788-9DA6B363-D3A7-4F4D-B86E-46712A39F28BQ89629012-BAF2ADA6-66BE-4F12-9FDF-DF9E77DB39C7Q95941828-D78BF433-1212-426B-9752-FC446762B644
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria V Periago
@ast
Maria V Periago
@en
Maria V Periago
@es
Maria V Periago
@nl
Maria V Periago
@sl
type
label
Maria V Periago
@ast
Maria V Periago
@en
Maria V Periago
@es
Maria V Periago
@nl
Maria V Periago
@sl
prefLabel
Maria V Periago
@ast
Maria V Periago
@en
Maria V Periago
@es
Maria V Periago
@nl
Maria V Periago
@sl
P106
P21
P31
P496
0000-0002-1470-5146